Gene therapy cost-effective for treating sickle cell disease in simulation models

1. In this cost analysis, compared to standard care, it was found that gene therapy for sickle cell disease (SCD) is cost-effective at a societal level based on two simulation models. 2. Acceptable value-based prices (VPBs) for SCD gene therapy ranged from $1 million to $2.5 million.  Evidence Rating Level: 2 (Good) Study Rundown: SCD […]

The post Gene therapy cost-effective for treating sickle cell disease in simulation models first appeared on 2 Minute Medicine.